Former President Trump plans to impose significant tariffs, potentially up to 200%, on imported pharmaceuticals, a sector largely exempt from previous trade wars. While Trump aims to lower drug costs, experts warn these tariffs risk the opposite, potentially leading to higher prices, supply chain disruptions, and shortages of affordable generic drugs. The policy seeks to bolster domestic manufacturing and address national security concerns regarding reliance on foreign suppliers, particularly after the COVID-19 pandemic highlighted vulnerabilities. However, analysts caution that even lower tariffs could substantially raise U.S. drug prices and that generic drugmakers might struggle to absorb the costs or relocate production without government aid.

Source: WIS10